« STEEPLE Study Revealed Superior Safety Profile of Sanofi-Aventis’ LOVENOX® (Enoxaparin Sodium Injection) Over Unfractionated Heparin (UFH) in Non-Emergent Percutaneous Coronary Intervention (PCI) Patients | Main | Introgen Therapeutics, Inc.’s ADVEXIN Therapy (p53 tumor suppressor) Showing Potential in Breast Cancer Treatment »

Sep11
Nextrials, Inc.’s Co-Founder Will Discuss Benefits of Integrating Electronic Healthcare and Clinical Trial Data at ExL Pharma's Second Annual Merging Electronic Health Records (EHR) and Electronic Data Capture (EDC) Conference

At the upcoming ExL Pharma's Second Annual Merging Electronic Health Records (EHR) and Electronic Data Capture (EDC) Conference slated on September 18-19 in Washington DC, Anthony J. Costello, Nextrials, Inc.’s co-founder and vice president and Society for Clinical Data Management (SCDM) chairman, will be a discussion panelist in a session entitled "The Benefits and Advantages," where Costello and other industry experts will discuss the merits of merging EHR and EDC, which include a potential reduction in medical errors and an increase in data quality.

According to Anthony J. Costello:

"The pharmaceutical industry has made great progress in its adoption of paperless research data collection applications such as Nextrials' Prism. An obvious next step is to work toward integrating EHR and EDC programs to create a patient clinical trail profile based partly on data already captured in hospital EHR systems.

Standards groups, regulators and the biopharma industry are using conferences like this one to share information and accelerate movement toward faster drug development timelines. There's a lot of work between here and there, but the potential benefits for patient safety and data quality make it worth engaging in the effort."

Those interested in learning more about the topic or in attending the conference can contact ExL Pharma at 866-247-9597 or visit their website.

Source: Nextrials, Inc. Press Release (a pdf file)

Hat tip: Mallory C. Nitchmann of VOXUS, Inc.

related entries


0 Comments/Trackbacks




submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« STEEPLE Study Revealed Superior Safety Profile of Sanofi-Aventis’ LOVENOX® (Enoxaparin Sodium Injection) Over Unfractionated Heparin (UFH) in Non-Emergent Percutaneous Coronary Intervention (PCI) Patients | Main | Introgen Therapeutics, Inc.’s ADVEXIN Therapy (p53 tumor suppressor) Showing Potential in Breast Cancer Treatment »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb